{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38330063", "DateCompleted": {"Year": "2024", "Month": "08", "Day": "07"}, "DateRevised": {"Year": "2024", "Month": "08", "Day": "07"}, "Article": {"Language": ["eng"], "ELocationID": ["e0284169", "10.1371/journal.pone.0284169"], "ArticleDate": [{"Year": "2024", "Month": "02", "Day": "08"}], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "19", "Issue": "2", "PubDate": {"Year": "2024"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis.", "Pagination": {"StartPage": "e0284169", "MedlinePgn": "e0284169"}, "Abstract": {"AbstractText": ["Dialysis is a replacement therapy for patients with End-Stage Renal Disease (ESRD). Patients on dialysis are at high risk of acquiring hepatitis C virus (HCV), which has become a leading cause of morbidity and mortality in this population. There is a wide range of prevalence of HCV in dialysis populations around the world. It is still unknown how prevalent HCV infection is among worldwide dialysis patients (including those undergoing hemodialysis and peritoneal dialysis). A review was conducted to estimate the global epidemiology of hepatitis C in dialysis patients. We searched PubMed, Excerpta Medica Database (Embase), Global Index Medicus and Web of Science until October 2022. A manual search of references from relevant articles was also conducted. Heterogeneity was evaluated by the \u03c72 test on Cochrane's Q statistic, and the sources of heterogeneity were investigated using subgroup analysis. In order to assess publication bias, funnel plots and Egger tests were conducted, and pooled HCV prevalence estimates were generated using a DerSimonian and Laird meta-analysis model. The study is registered with PROSPERO under CRD42022237789. We included 634 papers involving 392160 participants. The overall HCV case fatality rate was 38.7% (95% CI = 28.9-49). The global prevalence of HCV infection in dialysis population group were 24.3% [95% CI = 22.6-25.9]. As indicated by UNSD region, country, dialysis type, and HCV diagnostic targeted; Eastern Europe had the highest prevalence of 48.6% [95% CI = 35.2-62], Indonesia had 63.6% [95% CI = 42.9-82], hemodialysis patients had 25.5% [95% CI = 23.8-27.3], and anti-HCV were detected in 24.5% [95% CI = 22.8-26.2]. Dialysis patients, particularly those on hemodialysis, have a high prevalence and case fatality rate of HCV infection. Hemodialysis units need to implement strict infection control measures."], "CopyrightInformation": "Copyright: \u00a9 2024 Kenfack-Momo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Kenfack-Momo", "ForeName": "Raoul", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Ngounoue", "ForeName": "Marceline Djuidje", "Initials": "MD"}, {"Identifier": ["0000-0002-5536-080X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon."}], "LastName": "Kenmoe", "ForeName": "Sebastien", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Food, Food Security and Nutrition Research, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon."}], "LastName": "Takuissu", "ForeName": "Guy Roussel", "Initials": "GR"}, {"Identifier": ["0000-0002-4057-889X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Research Centre, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon."}], "LastName": "Ebogo-Belobo", "ForeName": "Jean Thierry", "Initials": "JT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Epidemiological Surveillance, Evaluation and Research Unit, National AIDS Control Committee, Douala, Cameroon."}], "LastName": "Kengne-Nd\u00e9", "ForeName": "Cyprien", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Mbaga", "ForeName": "Donatien Serge", "Initials": "DS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, University of Buea, Buea, Cameroon."}], "LastName": "Zeuko'o Menkem", "ForeName": "Elisabeth", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Animal Biology, University of Dschang, Dschang, Cameroon."}], "LastName": "Lontuo Fogang", "ForeName": "Robertine", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Scientific Direction, Centre Pasteur du Cameroun, Yaound\u00e9, Cameroon."}], "LastName": "Tchatchouang", "ForeName": "Serges", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Ndzie Ondigui", "ForeName": "Juliette Laure", "Initials": "JL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Research Centre, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon."}], "LastName": "Kame-Ngasse", "ForeName": "Ginette Irma", "Initials": "GI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Kenfack-Zanguim", "ForeName": "Josiane", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Magoudjou-Pekam", "ForeName": "Jeannette Nina", "Initials": "JN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Bowo-Ngandji", "ForeName": "Arnol", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine and Biomedical Sciences, University of Yaound\u00e9 1, Yaound\u00e9, Cameroon."}, {"Identifier": [], "Affiliation": "Hemodialysis Unit, Yaound\u00e9 General Hospital, Yaound\u00e9, Cameroon."}], "LastName": "Mahamat", "ForeName": "Maimouna", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon."}], "LastName": "Nkie Esemu", "ForeName": "Seraphine", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon."}], "LastName": "Ndip", "ForeName": "Lucy", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Virology Department, Centre Pasteur of Cameroon, Yaound\u00e9, Cameroon."}], "LastName": "Njouom", "ForeName": "Richard", "Initials": "R"}], "PublicationTypeList": ["Meta-Analysis", "Systematic Review", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Renal Dialysis"}, {"QualifierName": ["epidemiology"], "DescriptorName": "Hepatitis C"}, {"QualifierName": [], "DescriptorName": "Prevalence"}, {"QualifierName": [], "DescriptorName": "Hepacivirus"}, {"QualifierName": ["therapy", "epidemiology", "complications"], "DescriptorName": "Kidney Failure, Chronic"}, {"QualifierName": [], "DescriptorName": "Global Health"}], "CoiStatement": "The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Thrift A.P., El-Serag H.B., and Kanwal F., Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol, 2017. 14(2): p. 122\u2013132. doi: 10.1038/nrgastro.2016.176", "ArticleIdList": ["10.1038/nrgastro.2016.176", "27924080"]}, {"Citation": "Hepatitis C. 2022/09/24/07:09:27; Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c."}, {"Citation": "Soza A., Riquelme A., and Arrese M., Routes of transmission of hepatitis C virus. Annals of Hepatology, 2010. 9: p. S30\u2013S33.", "ArticleIdList": ["20713992"]}, {"Citation": "Ahmetagi\u0107 S., et al.., Hepatitis C infection in risk groups. Bosn J Basic Med Sci, 2006. 6(4): p. 13\u20137. doi: 10.17305/bjbms.2006.3111", "ArticleIdList": ["10.17305/bjbms.2006.3111", "PMC5807960", "17177641"]}, {"Citation": "Marinaki S., et al.., Hepatitis C in hemodialysis patients. World J Hepatol, 2015. 7(3): p. 548\u201358. doi: 10.4254/wjh.v7.i3.548", "ArticleIdList": ["10.4254/wjh.v7.i3.548", "PMC4381177", "25848478"]}, {"Citation": "Sit D., et al.., Seroprevalence of hepatitis B and C viruses in patients with chronic kidney disease in the predialysis stage at a university hospital in Turkey. Intervirology, 2006. 50(2): p. 133\u20137. doi: 10.1159/000098239", "ArticleIdList": ["10.1159/000098239", "17191015"]}, {"Citation": "Sun J., et al.., Hepatitis C infection and related factors in hemodialysis patients in china: systematic review and meta-analysis. Ren Fail, 2009. 31(7): p. 610\u201320. doi: 10.1080/08860220903003446", "ArticleIdList": ["10.1080/08860220903003446", "19839861"]}, {"Citation": "Su Y., et al.., Incidence of hepatitis C virus infection in patients on hemodialysis: A systematic review and meta-analysis: Meta-analysis of HCV in hemodialysis. Hemodialysis International, 2012: p. n/a-n/a.", "ArticleIdList": ["23072424"]}, {"Citation": "Goodkin D.A., et al.., Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis. Clin J Am Soc Nephrol, 2017. 12(2): p. 287\u2013297. doi: 10.2215/CJN.07940716", "ArticleIdList": ["10.2215/CJN.07940716", "PMC5293341", "27908905"]}, {"Citation": "Kidney Disease: Improving Global Outcomes Hepatitis, C.W.G., KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int Suppl (2011), 2018. 8(3): p. 91\u2013165.", "ArticleIdList": ["PMC6336217", "30675443"]}, {"Citation": "Hasanjani Roushan M.R., et al.., Epidemiological Aspects of Hepatitis B and C and Human Immunodeficiency Viruses Among Hemodialysis Patients in Mazandaran Province, Iran. Nephrourol Mon, 2016. 8(3): p. e37878. doi: 10.5812/numonthly.37878", "ArticleIdList": ["10.5812/numonthly.37878", "PMC4983454", "27570757"]}, {"Citation": "Pol S., et al.., Hepatitis C: Epidemiology, Diagnosis, Natural History and Therapy, in Contributions to Nephrology, Morales J.M., Editor. 2012, S. Karger AG. p. 1\u20139.", "ArticleIdList": ["22310776"]}, {"Citation": "Akhtar S., et al.., The prevalence of hepatitis C virus in hemodialysis patients in Pakistan: A systematic review and meta-analysis. PLoS One, 2020. 15(5): p. e0232931. doi: 10.1371/journal.pone.0232931", "ArticleIdList": ["10.1371/journal.pone.0232931", "PMC7224536", "32407423"]}, {"Citation": "Alavian S.-M., et al.. Hepatitis C infection in hemodialysis patients in Iran: A systematic review: Iranian hemodialysis HCV papers. Hemodialysis International, 2010. 14(3): p. 253\u2013262.", "ArticleIdList": ["20491973"]}, {"Citation": "Chemaitelly H., et al.., The epidemiology of hepatitis C virus in Afghanistan: systematic review and meta-analysis. Int J Infect Dis, 2015. 40: p. 54\u201363. doi: 10.1016/j.ijid.2015.09.011", "ArticleIdList": ["10.1016/j.ijid.2015.09.011", "26417880"]}, {"Citation": "Duong M.C., et al.., Prevalence of hepatitis B and C virus infections in hemodialysis patients in Vietnam: A systematic review and meta-analysis. JGH Open, 2020. 4(1): p. 29\u201338. doi: 10.1002/jgh3.12199", "ArticleIdList": ["10.1002/jgh3.12199", "PMC7008166", "32055694"]}, {"Citation": "Ghorbani N.R., et al.., Prevalence of hepatitis C infection in Iranian hemodialysis patients: An updated systematic review and meta-analysis. J Res Med Sci, 2017. 22: p. 123. doi: 10.4103/jrms.JRMS_223_17", "ArticleIdList": ["10.4103/jrms.JRMS_223_17", "PMC5721496", "29259634"]}, {"Citation": "Goel A., Seguy N., and Aggarwal R., Burden of hepatitis C virus infection in India: A systematic review and meta-analysis. J Gastroenterol Hepatol, 2019. 34(2): p. 321\u2013329. doi: 10.1111/jgh.14466", "ArticleIdList": ["10.1111/jgh.14466", "30176181"]}, {"Citation": "Niquini R.P., et al.., Persistently high hepatitis C rates in haemodialysis patients in Brazil [a systematic review and meta-analysis]. Sci Rep, 2022. 12(1): p. 330. doi: 10.1038/s41598-021-03961-x", "ArticleIdList": ["10.1038/s41598-021-03961-x", "PMC8748660", "35013390"]}, {"Citation": "Ramezan Ghorbani N., et al.., Oncogenic Viral Infections Among Iranian Hemodialysis Patients: A Systematic Review. Int J Prev Med, 2019. 10: p. 216. doi: 10.4103/ijpvm.IJPVM_458_17", "ArticleIdList": ["10.4103/ijpvm.IJPVM_458_17", "PMC6941381", "31929863"]}, {"Citation": "Adane T. and Getawa S., The prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa: A systematic review and meta-analysis. PLoS One, 2021. 16(6): p. e0251570. doi: 10.1371/journal.pone.0251570", "ArticleIdList": ["10.1371/journal.pone.0251570", "PMC8219139", "34157037"]}, {"Citation": "Ashkani-Esfahani S., Alavian S.M., and Salehi-Marzijarani M., Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis. World J Gastroenterol, 2017. 23(1): p. 151\u2013166. doi: 10.3748/wjg.v23.i1.151", "ArticleIdList": ["10.3748/wjg.v23.i1.151", "PMC5221279", "28104991"]}, {"Citation": "Cai G., et al.., Factors Correlating to the Development of Hepatitis C Virus Infection in Hemodialysis PatientsFindings Mainly from Asiatic Populations: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health, 2019. 16(8): p. 1453\u20131453. doi: 10.3390/ijerph16081453", "ArticleIdList": ["10.3390/ijerph16081453", "PMC6518179", "31022900"]}, {"Citation": "Goel A., et al.., Seroprevalence and burden of hepatitis C virus infection in WHO South-East Asia Region: A systematic review. J Gastroenterol Hepatol, 2022. 37(6): p. 964\u2013972. doi: 10.1111/jgh.15827", "ArticleIdList": ["10.1111/jgh.15827", "35263807"]}, {"Citation": "Huarez B., et al.., Prevalence of hepatitis C virus infection in patients with end-stage renal disease in Latin America and the Caribbean: a systematic review and meta-analysis. Arch Virol, 2022. doi: 10.1007/s00705-022-05604-6", "ArticleIdList": ["10.1007/s00705-022-05604-6", "36195804"]}, {"Citation": "Nguyen D.B., et al.., A Large Outbreak of Hepatitis C Virus Infections in a Hemodialysis Clinic. Infect Control Hosp Epidemiol, 2016. 37(2): p. 125\u201333. doi: 10.1017/ice.2015.247", "ArticleIdList": ["10.1017/ice.2015.247", "PMC4824294", "26573412"]}, {"Citation": "Rahnavardi M., Hosseini Moghaddam S.M., and Alavian S.M., Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures. Am J Nephrol, 2008. 28(4): p. 628\u201340.", "ArticleIdList": ["18285684"]}, {"Citation": "Greeviroj P., et al.., The world prevalence, associated risk factors and mortality of hepatitis C virus infection in hemodialysis patients: a meta-analysis. J Nephrol, 2022. 35(9): p. 2269\u20132282. doi: 10.1007/s40620-022-01483-x", "ArticleIdList": ["10.1007/s40620-022-01483-x", "PMC9666992", "36383211"]}, {"Citation": "Page M.J., et al.., The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev, 2021. 10(1): p. 89. doi: 10.1186/s13643-021-01626-4", "ArticleIdList": ["10.1186/s13643-021-01626-4", "PMC8008539", "33781348"]}, {"Citation": "Hoy D., et al.., Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol, 2012. 65(9): p. 934\u20139. doi: 10.1016/j.jclinepi.2011.11.014", "ArticleIdList": ["10.1016/j.jclinepi.2011.11.014", "22742910"]}, {"Citation": "DerSimonian R. and Laird N., Meta-analysis in clinical trials. Controlled Clinical Trials, 1986. 7(3): p. 177\u2013188. doi: 10.1016/0197-2456(86)90046-2", "ArticleIdList": ["10.1016/0197-2456(86)90046-2", "3802833"]}, {"Citation": "Higgins J.P., et al.., Measuring inconsistency in meta-analyses. BMJ, 2003. 327(7414): p. 557\u201360. doi: 10.1136/bmj.327.7414.557", "ArticleIdList": ["10.1136/bmj.327.7414.557", "PMC192859", "12958120"]}, {"Citation": "Egger M., et al.., Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997. 315(7109): p. 629\u201334. doi: 10.1136/bmj.315.7109.629", "ArticleIdList": ["10.1136/bmj.315.7109.629", "PMC2127453", "9310563"]}, {"Citation": "Pierce C.A., Software Review: Borenstein M., Hedges L. V., Higgins J. P. T., & Rothstein H. R. (2006). Comprehensive Meta-Analysis (Version 2.2.027) [Computer software]. Englewood, NJ: Biostat. Organizational Research Methods, 2008. 11(1): p. 188\u2013191."}, {"Citation": "Schwarzer G., meta: An R Package for Meta-Analysis. 2007. 7: p. 7."}, {"Citation": "Marcelli D., et al.., ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int, 1996. 50(3): p. 1013\u20138. doi: 10.1038/ki.1996.403", "ArticleIdList": ["10.1038/ki.1996.403", "8872978"]}, {"Citation": "Fabrizi F., Dixit V., and Messa P., Hepatitis C virus and mortality among patients on dialysis: A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol, 2019. 43(3): p. 244\u2013254. doi: 10.1016/j.clinre.2018.10.009", "ArticleIdList": ["10.1016/j.clinre.2018.10.009", "30910601"]}, {"Citation": "Fabrizi F., Dixit V., and Messa P., Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality? J Viral Hepat, 2012. 19(9): p. 601\u20137. doi: 10.1111/j.1365-2893.2012.01633.x", "ArticleIdList": ["10.1111/j.1365-2893.2012.01633.x", "22863263"]}, {"Citation": "Platt L., et al.., Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. The Lancet Infectious Diseases, 2016. 16(7): p. 797\u2013808. doi: 10.1016/S1473-3099(15)00485-5", "ArticleIdList": ["10.1016/S1473-3099(15)00485-5", "26922272"]}, {"Citation": "Simon N., et al.., A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney International, 1994. 46(2): p. 504\u2013511. doi: 10.1038/ki.1994.301", "ArticleIdList": ["10.1038/ki.1994.301", "7967364"]}, {"Citation": "Maisonneuve P., et al.., Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. The Lancet, 1999. 354(9173): p. 93\u201399. doi: 10.1016/s0140-6736(99)06154-1", "ArticleIdList": ["10.1016/s0140-6736(99)06154-1", "10408483"]}, {"Citation": "<natural history of HCV in HD.pdf>."}, {"Citation": "Goldblum S.E., Host Defenses and Immunologic Alterations Associated with Chronic Hemodialysis. Annals of Internal Medicine, 1980. 93(4): p. 597. doi: 10.7326/0003-4819-93-4-597", "ArticleIdList": ["10.7326/0003-4819-93-4-597", "7001976"]}, {"Citation": "<FRANCISCO Gomez.pdf>."}, {"Citation": "Salari N., et al.., Global prevalence of hepatitis C in general population: A systematic review and meta-analysis. Travel Med Infect Dis, 2022. 46: p. 102255. doi: 10.1016/j.tmaid.2022.102255", "ArticleIdList": ["10.1016/j.tmaid.2022.102255", "35007756"]}, {"Citation": "Jin F., et al.., Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 2021. 6(1): p. 39\u201356. doi: 10.1016/S2468-1253(20)30303-4", "ArticleIdList": ["10.1016/S2468-1253(20)30303-4", "33217341"]}, {"Citation": "Salari N., et al.., Global prevalence of hepatitis C in prisoners: a comprehensive systematic review and meta-analysis. Arch Virol, 2022. 167(4): p. 1025\u20131039. doi: 10.1007/s00705-022-05382-1", "ArticleIdList": ["10.1007/s00705-022-05382-1", "35165781"]}, {"Citation": "Corcoran G.D., et al.., Hepatitis C virus infection in haemodialysis patients: a clinical and virological study. J Infect, 1994. 28(3): p. 279\u201385. doi: 10.1016/s0163-4453(94)91793-0", "ArticleIdList": ["10.1016/s0163-4453(94)91793-0", "7522261"]}, {"Citation": "Shimokura G., et al.., Patient-care practices associated with an increased prevalence of hepatitis C virus infection among chronic hemodialysis patients. Infect Control Hosp Epidemiol, 2011. 32(5): p. 415\u201324. doi: 10.1086/659407", "ArticleIdList": ["10.1086/659407", "PMC3147181", "21515970"]}, {"Citation": "Kasraian L., et al.., The Prevalence of Hepatitis C Infection in Blood Donors: A Meta-Analysis and Systematic Review. Iranian Red Crescent Medical Journal, 2020. 22(1)."}, {"Citation": "Boulaajaj K., et al.., [Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca]. Nephrol Ther, 2006. 1(5): p. 274\u201384.", "ArticleIdList": ["16895696"]}, {"Citation": "Muller G.Y., et al.., Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int, 1992. 41(4): p. 1055\u20138. doi: 10.1038/ki.1992.160", "ArticleIdList": ["10.1038/ki.1992.160", "1381002"]}, {"Citation": "Oliva J.A., et al.., Markers of hepatitis C infection among hemodialysis patients with acute and chronic infection: implications for infection control strategies in hemodialysis units. Int J Artif Organs, 1995. 18(2): p. 73\u20137.", "ArticleIdList": ["7558399"]}, {"Citation": "Patient-to-Patient Transmission of Hepatitis C Virus. p. 3."}, {"Citation": "Hardy N.M., et al.., Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol, 1992. 38(1): p. 44\u20138.", "ArticleIdList": ["1499168"]}, {"Citation": "Pujol F.H., et al.., High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence. J Clin Microbiol, 1996. 34(7): p. 1633\u20136. doi: 10.1128/JCM.34.7.1633-1636.1996", "ArticleIdList": ["10.1128/JCM.34.7.1633-1636.1996", "PMC229084", "8784559"]}, {"Citation": "Hinrichsen H., et al.., Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut, 2002. 51(3): p. 429\u201333. doi: 10.1136/gut.51.3.429", "ArticleIdList": ["10.1136/gut.51.3.429", "PMC1773370", "12171969"]}, {"Citation": "Arenas M.D., et al.., [Nosocomial transmission of the hepatitis C virus in hemodialysis: monitors, personnel, or both?]. Nefrologia, 2002. 21(5): p. 476\u201384.", "ArticleIdList": ["11795017"]}, {"Citation": "Espinosa M., et al.., Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences. Am J Kidney Dis, 2004. 43(4): p. 685\u20139. doi: 10.1053/j.ajkd.2003.12.030", "ArticleIdList": ["10.1053/j.ajkd.2003.12.030", "15042545"]}, {"Citation": "Barril G., et al.., Prevalence of hepatitis C virus in dialysis patients in Spain. Nephrology Dialysis Transplantation, 1995. 10(SUPPL. 6): p. 78\u201380.", "ArticleIdList": ["8524503"]}, {"Citation": "<cdc recommendation.pdf>."}, {"Citation": "Agarwal S.K., Hemodialysis of Patients with HCV Infection: Isolation Has a Definite Role. Nephron Clinical Practice, 2010. 117(4): p. 328\u2013332.", "ArticleIdList": ["21051906"]}, {"Citation": "Jadoul M., Cornu C., and van Ypersele de Strihou C., Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group. Kidney Int, 1993. 44(6): p. 1322\u20136. doi: 10.1038/ki.1993.385", "ArticleIdList": ["10.1038/ki.1993.385", "7508005"]}, {"Citation": "<Michel Jadoul.pdf>."}, {"Citation": "Girou E., et al.., Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit. Clin Infect Dis, 2008. 47(5): p. 627\u201333. doi: 10.1086/590564", "ArticleIdList": ["10.1086/590564", "18662134"]}, {"Citation": "Saxena A.K., et al.., Impact of dedicated space, dialysis equipment, and nursing staff on the transmission of hepatitis C virus in a hemodialysis unit of the middle east. Am J Infect Control, 2003. 31(1): p. 26\u201333. doi: 10.1067/mic.2003.55", "ArticleIdList": ["10.1067/mic.2003.55", "12548254"]}, {"Citation": "Khan S., et al.., Rising burden of Hepatitis C Virus in hemodialysis patients. Virol J, 2011. 8: p. 438. doi: 10.1186/1743-422X-8-438", "ArticleIdList": ["10.1186/1743-422X-8-438", "PMC3180426", "21920054"]}, {"Citation": "Soliman A.R., Momtaz Abd Elaziz M., and El lawindi M.I., Evaluation of an Isolation Program of Hepatitis C Virus Infected Hemodialysis Patients in Some Hemodialysis Centers in Egypt. ISRN Nephrology, 2013. 2013: p. 1\u20135. doi: 10.5402/2013/395467", "ArticleIdList": ["10.5402/2013/395467", "PMC4045436", "24967226"]}, {"Citation": "Alfurayh O., et al.., Hepatitis C virus infection in chronic haemodialysis patients, a clinicopathologic study. Nephrol Dial Transplant, 1992. 7(4): p. 327\u201332. doi: 10.1093/oxfordjournals.ndt.a092137", "ArticleIdList": ["10.1093/oxfordjournals.ndt.a092137", "1375712"]}, {"Citation": "Caramelo C., et al.., Undiagnosed hepatitis C virus infection in hemodialysis patients: value of HCV RNA and liver enzyme levels. Kidney Int, 1996. 50(6): p. 2027\u201331. doi: 10.1038/ki.1996.525", "ArticleIdList": ["10.1038/ki.1996.525", "8943486"]}, {"Citation": "Seck S.M., et al.., Trends in hepatitis C infection among hemodialysis patients in Senegal: results of a decade of prevention. Saudi J Kidney Dis Transpl, 2014. 25(6): p. 1341\u20135. doi: 10.4103/1319-2442.144319", "ArticleIdList": ["10.4103/1319-2442.144319", "25394463"]}, {"Citation": "Yang C.-S., et al.., ISOLATION EFFECTIVELY PREVENTS THE TRANSMISSION OF HEPATITIS C VIRUS IN THE HEMODIALYSIS UNIT. J Formos Med Assoc, 2003. 102(2): p. 7.", "ArticleIdList": ["12709735"]}, {"Citation": "Gallego E., et al.., Effect of isolation measures on the incidence and prevalence of hepatitis C virus infection in hernodialysis. Nephron Clinical Practice, 2006. 104(1): p. C1\u2013C6.", "ArticleIdList": ["16685138"]}, {"Citation": "Carneiro M.A.S., et al.., Decline of hepatitis C infection in hemodialysis patients in Central Brazil: a ten years of surveillance. Mem\u00f3rias do Instituto Oswaldo Cruz, 2005. 100(4): p. 345\u2013349. doi: 10.1590/s0074-02762005000400002", "ArticleIdList": ["10.1590/s0074-02762005000400002", "16113881"]}, {"Citation": "Barril G. and Traver J.A., Decrease in the hepatitis C virus (HCV) prevalence in hemodialysis patients in Spain: effect of time, initiating HCV prevalence studies and adoption of isolation measures. Antiviral Res, 2003. 60(2): p. 129\u201334. doi: 10.1016/j.antiviral.2003.08.008", "ArticleIdList": ["10.1016/j.antiviral.2003.08.008", "14638409"]}, {"Citation": "Shamshirsaz A.A., et al.., The role of hemodialysis machines dedication in reducing Hepatitis C transmission in the dialysis setting in Iran: a multicenter prospective interventional study. BMC Nephrol, 2004. 5: p. 13. doi: 10.1186/1471-2369-5-13", "ArticleIdList": ["10.1186/1471-2369-5-13", "PMC529260", "15469615"]}, {"Citation": "Harmankaya O., et al.., Low prevalence of hepatitis C virus infection in hemodialysis units: effect of isolation? Ren Fail, 2002. 24(5): p. 639\u201344. doi: 10.1081/jdi-120013968", "ArticleIdList": ["10.1081/jdi-120013968", "12380910"]}, {"Citation": "Jadoul M., Cornu C., and St-Luc C., Universal precautions prevent hepatitis C virus transmission: A 54 month follow-up of the Belgian multicenter study. p. 4.", "ArticleIdList": ["9551413"]}, {"Citation": "Valtuille R., et al.., The role of transfusion-transmitted virus in patients undergoing hemodialysis. J Clin Gastroenterol, 2001. 34(1): p. 86\u20138.", "ArticleIdList": ["11743253"]}, {"Citation": "Gilli P., et al.., Prevention of Hepatitis C Virus in Dialysis Units. Nephron, 1995. 70(3): p. 301\u2013306. doi: 10.1159/000188608", "ArticleIdList": ["10.1159/000188608", "7477617"]}, {"Citation": "Carneiro M.A., et al.., Molecular and epidemiological study on nosocomial transmission of HCV in hemodialysis patients in Brazil. J Med Virol, 2007. 79(9): p. 1325\u201333. doi: 10.1002/jmv.20932", "ArticleIdList": ["10.1002/jmv.20932", "17607790"]}, {"Citation": "de Lamballerie X., et al.., Nosocomial transmission of hepatitis C virus in haemodialysis patients. J Med Virol, 1996. 49(4): p. 296\u2013302. doi: 10.1002/(SICI)1096-9071(199608)49:4&lt;296::AID-JMV7&gt;3.0.CO;2-Z", "ArticleIdList": ["10.1002/(SICI)1096-9071(199608)49:4&lt;296::AID-JMV7&gt;3.0.CO;2-Z", "8877762"]}, {"Citation": "Izopet J., et al.., Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit. J Med Virol, 1999. 58(2): p. 139\u201344. doi: 10.1002/(sici)1096-9071(199906)58:2&lt;139::aid-jmv7&gt;3.0.co;2-7", "ArticleIdList": ["10.1002/(sici)1096-9071(199906)58:2&lt;139::aid-jmv7&gt;3.0.co;2-7", "10335861"]}, {"Citation": "Hmaied F., et al.., Hepatitis C virus infection among dialysis patients in Tunisia: incidence and molecular evidence for nosocomial transmission. J Med Virol, 2005. 78(2): p. 185\u201391.", "ArticleIdList": ["16372289"]}, {"Citation": "Delarocque-Astagneau E., et al.., OUTBREAK OF HEPATITIS C VIRUS INFECTION IN A HEMODIALYSIS U N I T: POTENTIAL TRANSMISSION BY THE HEMODIALYSIS MACHINE? INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2002. 23(6): p. 7.", "ArticleIdList": ["12083237"]}, {"Citation": "Roy P., et al.., Prevalence and genotyping pattern of hepatitis C virus among patients on maintenance hemodialysis at five centers in Pune, India. Med J Armed Forces India, 2019. 75(1): p. 74\u201380.", "ArticleIdList": ["PMC6349655", "30705482"]}, {"Citation": "Savey A., et al.., A large nosocomial outbreak of hepatitis C virus infections at a hemodialysis center. Infect Control Hosp Epidemiol, 2005. 26(9): p. 752\u201360. doi: 10.1086/502613", "ArticleIdList": ["10.1086/502613", "16209381"]}, {"Citation": "Rinonce H.T., et al.., Hepatitis B and C virus infection among hemodialysis patients in yogyakarta, Indonesia: Prevalence and molecular evidence for nosocomial transmission: Hepatitis B and C in Indonesian Hemodialysis Patients. Journal of Medical Virology, 2013. 85(8): p. 1348\u20131361.", "ArticleIdList": ["23919229"]}, {"Citation": "Di Napoli A., et al.., Epidemiology of Hepatitis C Virus Among Long-Term Dialysis Patients: A 9-Year Study in an Italian Region. American Journal of Kidney Diseases, 2006. 48(4): p. 629\u2013637. doi: 10.1053/j.ajkd.2006.07.004", "ArticleIdList": ["10.1053/j.ajkd.2006.07.004", "16997059"]}, {"Citation": "Fernandez J.L., et al.., Serum hepatitis C virus RNA in anti-HCV negative hemodialysis patients. Serum hepatitis C virus RNA in anti-HCV negative hemodialysis patients, 1996. 25(1): p. 14\u201318."}, {"Citation": "Bukh J., et al.., High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group. The Journal of infectious diseases, 1993. 168(6): p. 1343\u20138. doi: 10.1093/infdis/168.6.1343", "ArticleIdList": ["10.1093/infdis/168.6.1343", "7504031"]}, {"Citation": "Kuhns M., et al.., Detection of hepatitis C virus RNA in hemodialysis patients. J Am Soc Nephrol, 1994. 4(7): p. 1491\u20137. doi: 10.1681/ASN.V471491", "ArticleIdList": ["10.1681/ASN.V471491", "7512832"]}, {"Citation": "Schr\u00f6ter M., et al.., High percentage of seronegative HCV infections in hemodialysis patients: the need for PCR. Intervirology, 1997. 40(4): p. 277\u20138. doi: 10.1159/000150558", "ArticleIdList": ["10.1159/000150558", "9612730"]}, {"Citation": "Seelig R., et al.., Hepatitis C virus infections in dialysis units: prevalence of HCV-RNA and antibodies to HCV. Ann Med, 1994. 26(1): p. 45\u201352. doi: 10.3109/07853899409147326", "ArticleIdList": ["10.3109/07853899409147326", "8166987"]}, {"Citation": "Singleton J., et al.., Electricity-free amplification and detection for molecular point-of-care diagnosis of HIV-1. PLoS One, 2014. 9(11): p. e113693. doi: 10.1371/journal.pone.0113693", "ArticleIdList": ["10.1371/journal.pone.0113693", "PMC4245218", "25426953"]}, {"Citation": "Furusyo N., et al.., Acute hepatitis C among Japanese hemodialysis patients: a prospective 9-year study. Am J Gastroenterol, 2001. 96(5): p. 1592\u2013600. doi: 10.1111/j.1572-0241.2001.03701.x", "ArticleIdList": ["10.1111/j.1572-0241.2001.03701.x", "11374705"]}, {"Citation": "Li Cavoli G., et al.., Hepatitis C virus core antigen test in monitoring of dialysis patients. Hepat Res Treat, 2012. 2012: p. 832021. doi: 10.1155/2012/832021", "ArticleIdList": ["10.1155/2012/832021", "PMC3523129", "23304475"]}, {"Citation": "Li Cavoli G., et al.., Hepatitis C virus core antigen in virological monitoring of dialysis patients. NDT Plus, 2010. 3: p. iii247.", "ArticleIdList": ["PMC5477968", "28657071"]}, {"Citation": "Duong M.C. and McLaws M.L., Screening haemodialysis patients for hepatitis C in Vietnam: The inconsistency between common hepatitis C virus serological and virological tests. J Viral Hepat, 2018. 26(1): p. 25\u201329. doi: 10.1111/jvh.12994", "ArticleIdList": ["10.1111/jvh.12994", "30187621"]}, {"Citation": "<hepatology2020.pdf>."}, {"Citation": "Dussol B., et al.., Detection of hepatitis C infection by polymerase chain reaction among hemodialysis patients. Am J Kidney Dis, 1993. 22(4): p. 574\u201380. doi: 10.1016/s0272-6386(12)80931-0", "ArticleIdList": ["10.1016/s0272-6386(12)80931-0", "8213798"]}, {"Citation": "Courouc\u00e9 A.M., et al.., Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays). Nephrol Dial Transplant, 1995. 10(2): p. 234\u20139.", "ArticleIdList": ["7538650"]}, {"Citation": "Castelnovo C., et al.., Comparison of three different tests for assessment of hepatitis C virus in dialysis patients. Perit Dial Int, 1995. 15(6): p. 241\u20135.", "ArticleIdList": ["7578501"]}, {"Citation": "Dalekos G.N., et al.., Absence of HCV viraemia in anti-HCV-negative haemodialysis patients. Nephrol Dial Transplant, 1998. 13(7): p. 1804\u20136. doi: 10.1093/ndt/13.7.1804", "ArticleIdList": ["10.1093/ndt/13.7.1804", "9681732"]}, {"Citation": "Nordenfelt E., et al.., Hepatitis C virus infection in hemodialysis patients in southern Sweden: epidemiological, clinical, and diagnostic aspects. J Med Virol, 1993. 40(4): p. 266\u201370. doi: 10.1002/jmv.1890400403", "ArticleIdList": ["10.1002/jmv.1890400403", "8228916"]}, {"Citation": "Sakamoto N., et al.., Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma. J Med Virol, 1993. 39(1): p. 11\u20135. doi: 10.1002/jmv.1890390104", "ArticleIdList": ["10.1002/jmv.1890390104", "7678636"]}]}], "History": [{"Year": "2023", "Month": "1", "Day": "24"}, {"Year": "2023", "Month": "3", "Day": "25"}, {"Year": "2024", "Month": "2", "Day": "11", "Hour": "7", "Minute": "19"}, {"Year": "2024", "Month": "2", "Day": "8", "Hour": "18", "Minute": "42"}, {"Year": "2024", "Month": "2", "Day": "8", "Hour": "13", "Minute": "54"}, {"Year": "2024", "Month": "2", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["38330063", "PMC10852299", "10.1371/journal.pone.0284169", "PONE-D-23-01990"]}}]}